ITP: Clinical Trials

5 trials for ITP, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 unknown. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Unknown 5

Follow ITP: new trials by email Literature Review of ITP trials Research Report on ITP

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Baricitinib for Steroid-resistant/Relapse Immune Thrombocytopenia
Baricitinib - ITP, Immune Thrombocytopenia
Phase 2UnknownPeking University People's Hospital352022-07-132022-09-28
Anti-BCMA CAR T-Cell Therapy for R/R ITP
autologous anti-BCMA chimeric antigen receptor T cells - ITP
Phase 2UnknownThe First Affiliated Hospital of Soochow University52022-01-012022-04-07
The Combination of Iguratimod and Danazol as the Treatment of Steroid-resistant/Relapse Immune Thrombocytopenia
Iguratimod, Danazol - ITP, Immune Thrombocytopenia
Phase 2UnknownPeking University People's Hospital1202021-09-012022-05-02
The Combination of Tacrolimus and High-dose Dexamethasone as First-line Treatment in Adult Immune Thrombocytopenia
Dexamethasone, Tacrolimus - ITP, Immune Thrombocytopenia
Phase 2UnknownPeking University People's Hospital1202021-03-012021-02-10
The DART Study- Daratumumab Treatment in ITP
Daratumumab Injection - ITP
Phase 2UnknownOstfold Hospital Trust212021-01-212024-04-09

Narrower conditions

Purpura, Thrombocytopenic, Idiopathic (3)

Broader conditions

Autoimmune Diseases (3)  ·  Blood Coagulation Disorders (3)  ·  Blood Platelet Disorders (3)  ·  Cytopenia (3)  ·  Hematologic Diseases (3)  ·  Hemic and Lymphatic Diseases (3)  ·  Hemorrhage (3)  ·  Hemorrhagic Disorders (3)  ·  Immune System Diseases (3)  ·  Pathologic Processes (3)  ·  Pathological Conditions, Signs and Symptoms (3)  ·  Purpura (3)  ·  Purpura, Thrombocytopenic (3)  ·  Signs and Symptoms (3)  ·  Skin Manifestations (3)

Interventions

Danazol (1)  ·  Dexamethasone (1)  ·  Tacrolimus (1)  ·  baricitinib (1)  ·  daratumumab (1)  ·  iguratimod (1)

Sponsors

Peking University People's Hospital (3)  ·  Ostfold Hospital Trust (1)  ·  The First Affiliated Hospital of Soochow University (1)

Countries

China (4)  ·  Denmark (1)  ·  France (1)  ·  Norway (1)

Top investigators

Waleed Ghanima, PhD (1)  ·  Xiao-Hui Zhang, MD (1)  ·  Xiaohui Zhang, MD (1)

Results publications

PMID 38980207, PMID 40763272